Ciaran Daniel Scallan is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of vaccine development, holding a total of 8 patents. His work focuses on creating innovative solutions for immunogenic responses in humans.

Latest Patents

Among his latest patents are formulations for small intestinal delivery of RSV and norovirus antigens. These compositions and methods aim to generate an immunogenic response in humans, providing a foundation for future vaccine development. Another notable patent involves alphavirus neoantigen vectors, which include nucleic acid sequences derived from tumors. This patent also encompasses methods and cells associated with these vectors, highlighting their potential use as vaccines.

Career Highlights

Ciaran has worked with several notable companies in the biotechnology sector, including Gritstone Bio, Inc. and Vaxart, Inc. His experience in these organizations has allowed him to advance his research and contribute to the development of groundbreaking vaccine technologies.

Collaborations

Ciaran has collaborated with esteemed colleagues such as Karin Jooss and Leonid Gitlin. These partnerships have further enriched his work and expanded the impact of his innovations in the field.

Conclusion

Ciaran Daniel Scallan is a key figure in the realm of vaccine innovation, with a strong portfolio of patents and collaborations. His contributions are paving the way for advancements in immunology and public health.

This text is generated by artificial intelligence and may not be accurate.